Cannabinoids decrease the K+ M-current in hippocampal CA1 neurons

Journal of Neuroscience

Volumn 20, Issue 1, 2000, Pages 51-58

  Schweitzer, Paul ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Brain; Cannabinoid; Excitation; Potassium current; Slice; Voltage clamp

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ATROPINE; CANNABINOID; CARBACHOL; ICOSANOID; LINOPIRDINE; METHANANDAMIDE; MUSCARINIC RECEPTOR; POTASSIUM CHANNEL; RIMONABANT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; NERVE CELL STIMULATION; NONHUMAN; POSTSYNAPTIC POTENTIAL; POTASSIUM CONDUCTANCE; POTASSIUM CURRENT; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; STEADY STATE; VOLTAGE CLAMP;

EID: 0033995148     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-01-00051.2000     Document Type: Article

References (53)

1. Aiken SP, Lampe BJ, Murphy PA, Brown BS (1995) Reduction of spike frequency adaptation and blockade of M-current in rat CA1 pyramidal neurones by linopirdine (DuP 996), a neurotransmitter release enhancer. Br J Pharmacol 115:1163-1168.
2. Ameri A (1999) The effects of cannabinoids on the brain. Prog Neurobiol 58:315-348.
3. Azouz R, Jensen MS, Yaari Y (1996) Ionic basis of spike after-depolarization and burst generation in adult rat hippocampal CA1 pyramidal cells. J Physiol (Lond) 492:211-223.
4. Biervert C, Schroeder BC, Kuhisch C, Berkovic SF, Propping P, Jentsch TJ, Steinlein OK (1998) A potassium channel mutation in neonatal human epilepsy. Science 279:403-406.
5. + current in a vertebrate neurone. Nature 283:673-676.
6. Chan PK, Yung WH (1998) Occlusion of the presynaptic action of cannabinoids in rat substantia nigra pars reticulata by cadmium. Neurosci Lett 249:57-60.
7. + channel gene in an idiopathic epilepsy family. Nat Genet 18:53-55.
8. + conductances in hippocampal CA1 neurons by serotonin. Nature 328:73-77.
9. Collins DR, Pertwee RG, Davies SN (1994) The action of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice. Eur J Pharmacol 259:R7-R8.
10. 2+ stores in rat sympathetic neurons. Proc Natl Acad Sci USA 95:7151-7156.
11. Deadwyler SA, Hampson RE, Bennett BA, Edwards TA, Mu J, Pacheco MA, Ward SJ, Childers SR (1993) Cannabinoids modulate potassium current in cultured hippocampal neurons. Receptors Channels 1:121-134.
12. Deadwyler SA, Hampson RE, Mu J, Whyte A, Childers S (1995) Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J Pharmacol Exp Ther 273:734-743.
13. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that hinds to the cannabinoid receptor. Science 258:1946-1949.
14. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz J-C, Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686-691.
15. Dutar P, Nicoll RA (1988) Classification of muscarinic responses in hippocampus in terms of receptor subtypes and second-messenger systems: electrophysiological studies in vitro. J Neurosci 8:4214-4224.
16. French ED, Dillon K, Wu X (1997) Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. NeuroReport 8:649-652.
17. Garcia DE, Brown S, Hille B, Mackie K (1998) Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. J Neurosci 18:2834-2841.
18. Gifford AN, Ashby Jr CR (1996) Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. J Pharmacol Exp Ther 277:1431-1436.
19. Halliwell JV, Adams PR (1982) Voltage-clamp analysis of muscarinic excitation in hippocampal neurons. Brain Res 250:71-92.
20. Henry DJ, Chavkin C (1995) Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci Lett 186:91-94.
21. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, De Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932-1936.
22. Himmi T, Perrin J, El Ouazzani T, Orsini JC (1998) Neuronal responses to cannabinoid receptor ligands in the solitary tract nucleus. Eur J Pharmacol 359:49-54.
23. Johnston D, Brown TH (1983) Interpretation of voltage-clamp measurements in hippocampal neurons. J Neurophysiol 50:464-486.
24. Keros S, McBain CJ (1997) Arachidonic acid inhibits transient potassium currents and broadens action potentials during electrographic seizures in hippocampal pyramidal and inhibitory interneurons. J Neurosci 17:3476-3487.
25. Lévénès C, Daniel H, Soubrié P, Crépel F (1998) Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells. J Physiol (Lond) 510:867-879.
26. 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology 126:125-131.
27. Mackie K, Lai Y, Westenbroek R, Mitchell R (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15:6552-6561.
28. Marrion NV (1997) Control of M-current. Annu Rev Physiol 59:483-504.
29. Martin BR (1986) Cellular effects of cannabinoids. Pharmacol Rev 38:45-74.
30. Matsuda LA, Lolait J, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564.
31. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, Vogel Z (1995) Identification of an endogenous 2-mono-glyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90.
32. Mechoulam R, Fride E, Di Marzo V (1998a) Endocannabinoids. Eur J Pharmacol 359:1-18.
33. Mechoulam R, Fride E, Ben-Shabat S, Meiri U, Horowitz M (1998b) Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid. Eur J Pharmacol 362:R1-R3.
34. Meves H (1994) Modulation of ion channels by arachidonic acid. Prog Neurobiol 43:175-186.
35. Miller AS, Walker JM (1995) Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata. Eur J Pharmacol 279:179-185.
36. Moore SD, Madamba SG, Joëls M, Siggins GR (1988) Somatostatin augments the M-current in hippocampal neurons. Science 239:278-280.
37. 2+ signals in cerebellar granule neurons in culture. J Neurosci 19:8765-8777.
38. 2+ channels in a neuronal expression system. Mol Pharmacol 49:707-714.
39. Piomelli D (1994) Eicosanoids in synaptic transmission. Crit Rev Neurobiol 8:65-83.
40. Rinaldi-Carmona M, Barth F, Héaulme F, Shire D, Calandra B, Congy C, Martinez S, Marauni J, Néliat G, Caput D, Ferrara P, Soubrié P, Breliere JC, LeFur G (1994) SR 141716A, a potent and selective antagonist of the brain cannahinoid receptor. FEBS Lett 350:240-244.
41. Schmitt H, Meves H (1993) Protein kinase C as mediator of arachidonic acid-induced decrease of neuronal M current. Pflügers Arch 425:134-139.
42. Schweitzer P, Madamba SG, Siggins GR (1990) Arachidonic acid metabolites as mediators of somatostatin-induced increase of neuronal M-current. Nature 346:464-467.
43. Schweitzer P, Madamba SG, Champagnat J, Siggins GR (1993) Somatostatin inhibition of hippocampal CA1 pyramidal neurons: mediation by arachidonic acid and its metabolites. J Neurosci 13:2033-2049.
44. Shen MX, Thayer SA (1998) The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons. Brain Res 783:77-84.
45. Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773-778.
46. Storm JF (1990) Potassium currents in hippocampal pyramidal cells. Prog Brain Res 83:161-187.
47. 2+ transient in NG108-15 cells. J Biochem 122:890-895.
48. Szabo B, Dörner L, Pfreundtner C, Nörenberg W, Starke K (1998) Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience 85:395-403.
49. Tsou K, Brown S, Sañudo-Peña MC, Mackie K, Walker JM (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83:393-411.
50. Twitchell W, Brown S, Mackie K (1997) Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol 78:43-50.
51. Wang HS, Pan ZM, Shi WM, Brown BS, Wymore RS, Cohen IS, Dixon JE, McKinnon D (1998) KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 282:1890-1893.
52. Williams JH, Errington ML, Lynch MA, Bliss TVP (1989) Arachidonic acid induces a long-term activity-dependent enhancement of synaptic transmission in the hippocampus. Nature 341:739-742.
53. Xue BG, Belluzzi JD, Stein L (1993) In vitro reinforcement of hippocampal bursting by the cannabinoid receptor agonist (-)CP-55,940. Brain Res 626:272-277.